Protective effect of tolvaptan against cyclophosphamide‐induced nephrotoxicity in rat models
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protective effect of tolvaptan against cyclophosphamide‐induced nephrotoxicity in rat models
Authors
Keywords
-
Journal
Pharmacology Research & Perspectives
Volume 8, Issue 5, Pages -
Publisher
Wiley
Online
2020-09-30
DOI
10.1002/prp2.659
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Renoprotective effect of tolvaptan in patients with new‐onset acute heart failure
- (2020) Hiromi Kin et al. ESC Heart Failure
- Tolvaptan activates the Nrf2/HO-1 antioxidant pathway through PERK phosphorylation
- (2019) Tamami Fujiki et al. Scientific Reports
- Bone marrow-derived versus adipose-derived stem cells in wound healing: value and route of administration
- (2018) Basma Emad Aboulhoda et al. CELL AND TISSUE RESEARCH
- Naringin protects against cyclophosphamide-induced hepatotoxicity and nephrotoxicity through modulation of oxidative stress, inflammation, apoptosis, autophagy, and DNA damage
- (2018) Cuneyt Caglayan et al. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
- Renoprotective effects of tolvaptan in hypertensive heart failure rats depend on renal decongestion
- (2018) Hiroki Chiba et al. HYPERTENSION RESEARCH
- Effectiveness of tolvaptan monotherapy and low-dose furosemide/tolvaptan combination therapy for hepatoprotection and diuresis in a rat cirrhotic model
- (2017) Norikazu Tanabe et al. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
- Cancer and the kidney: dangereoux liasons or price paid for the progress in medicine?
- (2017) Jolanta Małyszko et al. Oncotarget
- Rutin ameliorates cyclophosphamide induced oxidative stress and inflammation in Wistar rats: Role of NFκB/MAPK pathway
- (2015) Sana Nafees et al. CHEMICO-BIOLOGICAL INTERACTIONS
- 18β-Glycyrrhetinic acid exerts protective effects against cyclophosphamide-induced hepatotoxicity: potential role of PPARγ and Nrf2 upregulation
- (2015) Ayman M. Mahmoud et al. Genes and Nutrition
- Urinary excretion of the water channel aquaporin 2 correlated with the pharmacological effect of tolvaptan in cirrhotic patients with ascites
- (2015) Hiroyuki Nakanishi et al. JOURNAL OF GASTROENTEROLOGY
- 18β-Glycyrrhetinic acid exerts protective effects against cyclophosphamide-induced hepatotoxicity: potential role of PPARγ and Nrf2 upregulation
- (2015) Ayman M. Mahmoud et al. Genes and Nutrition
- Chrysin alleviates acute doxorubicin cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis
- (2014) Eman M. Mantawy et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Berberine mitigates cyclophosphamide-induced hepatotoxicity by modulating antioxidant status and inflammatory cytokines
- (2014) Mousa O. Germoush et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH)
- (2014) A. Peri et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Tolvaptan for the treatment of liver cirrhosis oedema
- (2014) Isao Sakaida Expert Review of Gastroenterology & Hepatology
- Intervention in cyclophosphamide induced oxidative stress and DNA damage by a flavonyl-thiazolidinedione based organoselenocyanate and evaluation of its efficacy during adjuvant therapy in tumor bearing mice
- (2013) Somnath Singha Roy et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Amelioration of cyclophosphamide-induced hepatotoxicity by the root extract of Decalepis hamiltonii in mice
- (2013) Mahsa Zarei et al. FOOD AND CHEMICAL TOXICOLOGY
- Mechanism for the protective effect of diallyl disulfide against cyclophosphamide acute urotoxicity in rats
- (2013) Sung-Hwan Kim et al. FOOD AND CHEMICAL TOXICOLOGY
- Renoprotective Effect of Vasopressin V2 Receptor Antagonist Tolvaptan in Dahl Rats With End-Stage Heart Failure
- (2013) Mayuko Ishikawa et al. International Heart Journal
- Chronic Administration of Oral Vasopressin Type 2 Receptor Antagonist Tolvaptan Exerts Both Myocardial and Renal Protective Effects in Rats With Hypertensive Heart Failure
- (2012) Hanako Morooka et al. Circulation-Heart Failure
- Cyclophosphamide-induced nephrotoxicity, genotoxicity, and damage in kidney genomic DNA of Swiss albino mice: the protective effect of Ellagic acid
- (2012) Muneeb U. Rehman et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The Protective Effects of Spirulina in Cyclophosphamide Induced Nephrotoxicity and Urotoxicity in Rats
- (2012) Orhun Sinanoglu et al. UROLOGY
- Hyponatremia and antidiuresis syndrome
- (2011) Marie-Christine Vantyghem et al. ANNALES D ENDOCRINOLOGIE
- Efficacy and Safety of Tolvaptan in Heart Failure Patients with Sustained Volume Overload despite the Use of Conventional Diuretics: A Phase III Open-Label Study
- (2011) Masatake Fukunami et al. CARDIOVASCULAR DRUGS AND THERAPY
- The effects of oral glutamine on cyclophosphamide-induced nephrotoxicity in rats
- (2010) Premila Abraham et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- Incidence of hyponatremia in children with gastroenteritis treated with hypotonic intravenous fluids
- (2010) Mina Hanna et al. PEDIATRIC NEPHROLOGY
- Uroprotective Effects of Curcumin in Cyclophosphamide-Induced Haemorrhagic Cystitis Paradigm
- (2009) Hossam M. M. Arafa BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Urological implications of cyclophosphamide and ifosfamide
- (2008) Malcolm Lawson et al. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now